Description Code
Lamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg
HIV, Pharmaceutical Products
Lamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg
Fixed-dose combination tablet of Lamivudine 150 mg, Zidovudine 300 mg, and Nevirapine 200 mg for HIV-1 treatment.
Form: Film-coated tablet
Manufacturer: Cipla Ltd.
Country of Origin: India
| Composition | Lamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg |
|---|---|
| Pack Size | Strip of 30 tablets |
| Form | Film-coated tablet |
| Administration Route | Oral (with or without food, preferable fixed schedule) |
| Dosage Regimen | One tablet twice daily, or as prescribed |
| Usage Indications | HIV-1 infection (as part of combination ART) |
| Country of Origin | India |
| Manufacturer | Cipla Ltd. |
| Prescription Status | Rx required |
| Storage Conditions | Store below 25 °C |
| Shelf Life | 24 months (typical) |
| Common Side Effects | abdominal pain, diarrhea, fever, headache, muscle pain, nausea, rash |
| Precautions | liver/renal function; caution in pregnancy/breastfeeding; may cause bone marrow suppression and hypersensitivity, Take consistently; monitor blood counts |
Related products
Tenofovir Alafenamide 25 mg
HIVTenofovir Alafenamide 25 mg tablet used in the treatment of chronic hepatitis B (HBV) infection.
Linezolid (600mg) Tablet – Lizolid 600
AntibioticsTreats severe bacterial infections, including pneumonia and skin infections.
Tenofovir DF 300 mg + Emtricitabine 200 mg
HIVOral fixed-dose combination of Tenofovir Disoproxil Fumarate 300 mg & Emtricitabine 200 mg for HIV-1 suppression and prophylaxis.
Reviews
There are no reviews yet.